跳至主要内容
临床试验/TCTR20160725002
TCTR20160725002招募中4 期

Effects of N-acetylcysteine on cardiovascular parameters in thalassemia major patients

The Faculty of Medicine Endowment fund0 个研究点目标入组 100 人开始时间: 2016年7月25日最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 0 N/A (No limit)(—)
性别
All

入选标准

  • All diagnosed thalassemia major patients aged 18 years or older currently treated with regular blood transfusion and iron chelation therapy

排除标准

  • Patients will be excluded if they have apparent heart diseases, diabetes mellitus, atrial flutter, atrial fibrillation, thyrotoxicosis, pacemaker installation, or had been taking any
  • medications, which affected autonomic function including contraceptive, tricyclic antidepressant, anticholinergic agents, amphotericin B, calcium channel blocker, beta-blocker, antiarrhythmic, and centrally acting antihypertensive agents.

研究者

发起方
The Faculty of Medicine Endowment fund

相似试验

Effects of N-acetylcysteine on cardiovascular... | 临床试验